TLC-ART Program

February 22, 2022

TLC-ART Lab Update on HIV Therapies at LEAP Conference


Seattle, WA (Feb 12, 2022)–Earlier this month, Dr. Rodney Ho presented updates on the TLC-ART program’s Unitaid funded Global Long-Acting Drug Development (GLAD) Project at the LEAP (Lon-Acting/Extended Release Antiretroviral Research Resource Program) annual meeting. As part of this meeting, Dr. Ho lectured on the progress of the GLAD project in transforming the current best-of-class…

December 9, 2021

TLC-ART and MPP sign a licence agreement for a long-acting injectable candidate for HIV

TLC-ART program signs a license agreement with MPP to develop long-acting HIV therapeutics.

September 14, 2021

FDA Approves TLC Alumnus John Hoekman’s Migraine-Treating Nasal Spray

Drs. Hoekman and Ho

FDA Approves TLC Alumnus Dr. Hoekman’s Migraine Therapy.

December 21, 2020

TLC-ART Director Dr. Rodney JY Ho Named to National Academy of Inventors

Dr. Rodney Ho

TLC-ART is honored to announce that Director and UWSOP Professor of Pharmaceutics Rodney JY Ho has been elected to the rank of NAI Fellow by the 2020 National Academy of Inventors Fellows Selection Committee and Board of Directors. “Dr. Ho has demonstrated a highly prolific spirit of innovation in creating or facilitating outstanding inventions that…

November 23, 2020

Dr. Ho Talks Pfizer and COVID-19 Vaccine Distribution with KOMO News 4


Dr. Rodney Ho, Executive Director of WE-REACH, discussed the Pfizer COVID-19 vaccine and the challenges of distributing a treatment that requires -80 degree Celsius freezer storage with KOMO News last Friday. While “it is logistically challenging,” Dr. Ho believes that “we have prepared the best as we can.” For the full story, follow the link…

July 6, 2020

Drug Topics Covers HIV, COVID-19, and the Role of Pharmacists with Dr. Ho

Drug Topics, a major publication for pharmacists with over 150,000 readers, recently spoke with Dr. Ho about the crucial role of pharmacists in treating the dual crises of COVID-19 and HIV. With the rise of telehealth and the need to understand drug-drug interactions, pharmacists have never been more important for the practice of medicine. For…

June 4, 2020

KUOW Questions Dr. Ho on FDA Regulations and COVID-19 Testing

Ann Dornfeld, a reporter at KUOW (a local affiliate of NPR), featured Dr. Ho in an article titled “False advertising: This Seattle doctor set up a dubious Covid testing site in a vacant hotel.” In the article, Dr. Ho discusses the issues with FDA oversight of new COVID-19 tests and the problem of false claims…

May 11, 2020

The Healthy Talks Antibody Testing with Dr. Ho

The Healthy, an imprint of Reader’s Digest covering health has posted an Amanda Gardner article featuring Dr. Ho. Here, Dr. Ho discusses the role of antibody testing in COVID-19. The article, titled “Coronavirus Testing: Everything You Need to Know”can be found at the link.

April 5, 2020

Knowable Magazine Features Dr. Ho in COVID-19 Newsletter

Knowable Magazine featured Dr. Ho in a discussion on the possible links between the use of non-steroidal anti-inflammatory drugs (NSAIDS) and worsened COVID-19 symptoms. For the whole piece, follow the link.

March 26, 2020

KOMO News 4 Interviews Dr. Ho on COVID-19

Watch Dr. Ho explain how antivirals might only be effective for early stage treatment of COVID-19. KOMO News 4 of Seattle covered the story. For the full talk, follow the link.

Next page